Insulin Resistance Indexes as Biomarkers of Lifetime Cardiovascular Risk among Adults from Peru

Table 2

Cardiometabolic variables of participants by lifetime cardiovascular risk and sex.

Variables	Men		value	Women		value
	High^a (n = 38)	Low^a (n = 46)		High^a (n = 29)	Low^a (n = 178)
Age (years)	47 ± 9	48 ± 11	0.668	52 ± 8	44 ± 10	0.001
Weight (kg)	82.8 ± 15.1	69.2 ± 9.1	<0.001	72.7 ± 10.8	63.5 ± 10.8	<0.001
SBP (mmHg)	118 ± 11	111 ± 13	0.010	114 ± 13	104 ± 12	<0.001
DBP (mmHg)	77 ± 12	71 ± 11	0.014	71 ± 9	66 ± 9	0.007
BMI (kg/m^2)	30.5 ± 4.7	26.4 ± 2.5	<0.001	31.2 ± 4.6	27.4 ± 4.0	<0.001
WC (cm)	100.4 ± 15.5	92.3 ± 7.0	0.002	96.7 ± 9.2	89.0 ± 9.2	<0.001
Glucose (mg/dL)	111.8 ± 47.3	91.7 ± 8.8	0.006	120.4 ± 75.8	89.6 ± 13.1	<0.001
HbA1c (%)	6.47 ± 1.78	5.78 ± 0.29	0.012	6.86 ± 1.56	5.85 ± 0.67	<0.001
Cholesterol (mg/dL)	213.0 ± 35.3	183.5 ± 34.8	<0.001	221.6 ± 39.9	186.4 ± 33.1	<0.001
LDL-C (mg/dL)	133.3 ± 28.1	107.0 ± 29.1	<0.001	138.2 ± 40.4	108.6 ± 25.3	<0.001
VLDL-C (mg/dL)	36.3 ± 12.6	27.4 ± 14.2	0.003	35.0 ± 11.0	26.4 ± 11.7	<0.001
HDL-C (mg/dL)	44.9 ± 8.4	49.1 ± 7.9	0.021	48.3 ± 10.2	51.5 ± 10.9	0.143
Triglycerides (mg/dL)	211.9 ± 99.0	136.8 ± 70.9	<0.001	188.1 ± 67.5	135.8 ± 67.0	<0.001
Chol/HDL-C	4.84 ± 0.86	3.75 ± 0.53	<0.001	4.73 ± 1.12	3.75 ± 1.01	<0.001
TG/HDL-C	4.79 ± 2.23	2.81 ± 1.38	<0.001	4.13 ± 1.80	2.82 ± 1.75	<0.001
TyG	9.20 ± 0.69	8.64 ± 0.46	<0.001	9.17 ± 0.50	8.60 ± 0.50	<0.001
Uric acid (mg/dL)	4.8 ± 0.9	4.6 ± 0.8	0.284	3.7 ± 0.8	3.4 ± 0.9	0.114

Data expressed as mean ± standard deviation. SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; WC, waist circumference; HbA1c, glycated hemoglobin; LDL-C, low-density lipoproteins; VLDL-C, very low-density lipoproteins cholesterol; HDL-C, high-density lipoproteins cholesterol; Chol/HDL-C, total cholesterol to HDL-cholesterol ratio; TG/HDL-C, triglycerides to HDL-cholesterol ratio; TyG, triglyceride glucose index. ^aLifetime cardiovascular risk.